Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Integra LifeSciences Completes Metasurg Product Portfolio Acquisition - Orthopedic Design & Technology
Financial/Business, OEM News

Integra LifeSciences Completes Metasurg Product Portfolio Acquisition

Buy adds lower extremity products to Integra's offerings.

Plainsboro, N.J.-based Integra LifeSciences Holdings Corporation has closed the acquisition of Metasurg’s product portfolio.

The Metasurg product portfolio adds implant systems to Integra’s lower extremity product offering. It also offers the opportunity to distribute a biologic allograft derived from human placental tissue as a possible complement to Integra’s wound care product offering.

Metasurg’s revenues in 2013 were approximately $6 million, with growth in the double digits over the prior year period. The company expects minimal impact on profits in 2015 and slower growth during the transition period, before returning to double-digit growth longer term.

Metasurg was founded in 2005 in Houston, Texas, with the goal of providing foot and ankle surgeons intuitive, easy-to-use implant systems. The company has commercialized a variety of implant systems, launching five products over the last several years.

Integra provides solutions in regenerative technology, specialty surgical solutions, orthopedics and tissue technologies, and spine hardware and orthobiologics.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters